Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia

Condition:   Pneumonia, Bacterial Interventions:   Drug: CAL02;   Drug: Placebo Sponsor:   Eagle Pharmaceuticals, Inc. Not yet recruiting

Source: ClinicalTrials.gov - March 20, 2023 Category: Research Source Type: clinical trials